-
Mashup Score: 0Podcast Chirag Shah, MD @CShahMD @ClevelandClinic #Miam - 2 year(s) ago
Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at Cleveland Clinic. In th
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Erika Hamilton, MD @ErikaHamilton9 @SarahCannonDocs #On - 2 year(s) ago
Erika Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator at Sarah Cannon Research Institute. In this vid
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👩⚕️ Dr. @ErikaHamilton9 from @SarahCannonDocs spoke with us about the Safety 🆙date: DESTINY-Breast0️⃣3️⃣ Phase 3️⃣ Trial 👫 with HER2️⃣-positive MBC. #OncoTwitter @OncoAlert 📺 https://t.co/IC3Z1tNclm https://t.co/on0VjknltP
-
-
Mashup Score: 3Podcast Jonathan Zager, MD @jzager99 @MoffittNews #ASCO - 2 year(s) ago
Jonathan Zager, MD, Chief Academic Officer, Chair, USF Department of Oncologic Sciences at Moffitt Cancer Center. In this audio, he speaks about the ASCO 2
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👨⚕️ Dr. @jzager99 from @MoffittNews spoke with us about the #ASCO22 Abstract - Phase 3️⃣ FOCUS Trial, 👫 that have progressed from the 👁️ to the liver. #OncoTwitter @oncoalert 🔊 https://t.co/6wNqq4hLcp https://t.co/17XBA4ziaX
-
-
Mashup Score: 0Jonathan Zager, MD @jzager99 @MoffittNews #ASCO22 #Onco - 2 year(s) ago
Jonathan Zager, MD, Chief Academic Officer, Chair, USF Department of Oncologic Sciences at Moffitt Cancer Center. In this video, he speaks about the ASCO 2
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👨⚕️ Dr. @jzager99 from @MoffittNews spoke with us about the #ASCO22 Abstract - Phase 3️⃣ FOCUS Trial, 👫 that have progressed from the 👁️ to the liver. #OncoTwitter @oncoalert 📺 https://t.co/m8tG1LRrSe https://t.co/n9bPMTOh4e
-
-
Mashup Score: 0Samuel J Klempner, MD @KlempnerSam @MassGeneralNews @MG - 2 year(s) ago
Samuel J Klempner, MD a gastrointestinal medical oncologist with a clinical and research focus in upper GI cancers, specifically gastroesophageal cancers a
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/aoRjReXcr4
-
-
Mashup Score: 0Podcast Erika Hamilton, MD @ErikaHamilton9 @SarahCannon - 2 year(s) ago
Erika Hamilton, MD, Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator at Sarah Cannon Research Institute. In this aud
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👩⚕️ Dr. @ErikaHamilton9 from @SarahCannonDocs spoke with us about the Safety 🆙date: DESTINY-Breast0️⃣3️⃣ Phase 3️⃣ Trial 👫 with HER2️⃣-positive MBC. #OncoTwitter @OncoAlert 🔊 https://t.co/Latas007xI https://t.co/ZVF7WOKwVM
-
-
Mashup Score: 1Podcast Thomas George, MD @TGeorgeMD @UFHealthCancer @N - 2 year(s) ago
Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this audio, he speaks about the ASCO 2022 Abstract – NSABP FC-1
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👨⚕️ Dr. @TGeorgeMD from @UFHealthCancer, along with @HH_Oncodr, @CaioRLOnc, @jcfabregas, @aakonc, @GregYothers, 🗣️ about the #ASCO22 - NSABP FC-1️⃣2️⃣: A Single-arm, Phase II Study. @NateraGenetics @Novartis #OncoTwitter @oncoalert 🔊 https://t.co/tIokfU5ujP https://t.co/3ARrCfHkJ4
-
-
Mashup Score: 1Thomas George, MD @TGeorgeMD @UFHealthCancer @NSABPFoun - 2 year(s) ago
Thomas George, MD, FACP, Professor, MD-Hematology/Oncology from UF Health Cancer Center. In this video, he speaks about the ASCO 2022 Abstract – NSABP FC-1
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👨⚕️ Dr. @TGeorgeMD from @UFHealthCancer, along with @HH_Oncodr, @CaioRLOnc, @jcfabregas, @aakonc, @GregYothers, 🗣️ about the #ASCO22 - NSABP FC-1️⃣2️⃣: A Single-arm, Phase II Study. @NateraGenetics @Novartis #OncoTwitter @oncoalert 📺 https://t.co/gq6wd8Qgyn https://t.co/jh1izJHSNw
-
-
Mashup Score: 0Cansu Bozkus, PhD @CimenBozkus_C @BhardwajLab @TischCan - 2 year(s) ago
Cansu Cimen Bozkus, PhD, Assistant Professor at Icahn School of Medicine at Mount Sinai. In this video, she speaks about the AACR 2022 abstract – 253 / 19
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/w1JZHTSIhk
-
-
Mashup Score: 1Podcast Richard Woodman, MD @EisaiUS #ASCO22 #OncoTwitt - 2 year(s) ago
Richard Woodman, MD Chief Clinical Officer, Oncology Business Group at Eisai, Inc.. In this video, he speaks about the ASCO 2022 Abstract – Efficacy of nex
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
https://t.co/5S3Vs5h1ZW
-
https://t.co/k4ibcVKgMK